René Núñez

442 total citations
19 papers, 331 citations indexed

About

René Núñez is a scholar working on Psychiatry and Mental health, Pharmacology and Rheumatology. According to data from OpenAlex, René Núñez has authored 19 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 4 papers in Rheumatology. Recurrent topics in René Núñez's work include Treatment of Major Depression (8 papers), Bipolar Disorder and Treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). René Núñez is often cited by papers focused on Treatment of Major Depression (8 papers), Bipolar Disorder and Treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). René Núñez collaborates with scholars based in United States, India and Chile. René Núñez's co-authors include Carl Gommoll, Maju Mathews, Dalei Chen, Arif Khan, Xiongwen Tang, Suresh Durgam, Harry A. Croft, Nunzio Pomara, William M. Greenberg and Changzheng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Schizophrenia Bulletin.

In The Last Decade

René Núñez

18 papers receiving 321 citations

Peers

René Núñez

PHARM

PMH

ECP

Lovisa Berggren United States

Doron Mazeh Israel

Alina Wilkowska Poland

Anna Julia Krupa Poland

Toni Lock United Kingdom

Scott T. Aaronson United States

F. Baldinetti United States

Jean‐Michel Germain United States

J Markowitz United States

Timothy J. Martin United Kingdom

Lovisa Berggren United States

René Núñez

103 ×0.5

PHARM

178 ×1.1

PMH

42 ×0.4

ECP

29 ×0.5

31 ×0.6

Citations per year, relative to René Núñez René Núñez (= 1×) peers Lovisa Berggren

Countries citing papers authored by René Núñez

Since Specialization

Citations

This map shows the geographic impact of René Núñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Núñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Núñez more than expected).

Fields of papers citing papers by René Núñez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Núñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Núñez. The network helps show where René Núñez may publish in the future.

Co-authorship network of co-authors of René Núñez

This figure shows the co-authorship network connecting the top 25 collaborators of René Núñez. A scholar is included among the top collaborators of René Núñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Núñez. René Núñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Espinoza, Ignacio, et al.. (2024). Temporomandibular joint study by magnetic resonance imaging: it is time to inform. SHILAP Revista de lepidopterología. 30(3).

Darwish, Mona, Thomas Marbury, René Núñez, et al.. (2024). Physiologically-Based Pharmacokinetic Modeling of Trofinetide in Moderate Renal Impairment for Phase 1 Clinical Study Dose Selection with Model Validation. European Journal of Drug Metabolism and Pharmacokinetics. 50(1). 23–38. 1 indexed citations

Darwish, Mona, René Núñez, James M. Youakim, & Philmore Robertson. (2023). Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects. Clinical Drug Investigation. 44(1). 21–33. 7 indexed citations

Bugarski‐Kirola, Dragana, et al.. (2022). Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia. Frontiers in Psychiatry. 13. 892199–892199. 5 indexed citations

Núñez, René, et al.. (2021). Rheumatoid meningitis: report of two cases. Revista médica de Chile. 149(2). 295–303. 3 indexed citations

Núñez, René, et al.. (2021). Rheumatoid meningitis: A systematic review and meta‐analysis. European Journal of Neurology. 28(9). 3201–3210. 25 indexed citations

Alva, Gustavo, Jason Aldred, Bruce Coate, et al.. (2020). An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson’s Disease and Depression. Journal of Parkinson s Disease. 10(4). 1751–1761. 13 indexed citations

Bugarski‐Kirola, Dragana, René Núñez, Mohammed Abdul Bari, et al.. (2020). T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT. Schizophrenia Bulletin. 46(Supplement_1). S247–S247. 1 indexed citations

Durgam, Suresh, Carl Gommoll, René Núñez, et al.. (2016). Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 77(12). 1687–1694. 17 indexed citations

10.

Gommoll, Carl, Maju Mathews, René Núñez, et al.. (2015). Vilazodone in patients with generalized anxiety disorder. International Clinical Psychopharmacology. 30(6). 297–306. 22 indexed citations

11.

Clayton, Anita H., Carl Gommoll, Dalei Chen, René Núñez, & Maju Mathews. (2015). Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo. International Clinical Psychopharmacology. 30(4). 216–223. 26 indexed citations

12.

Guenther, Garret, et al.. (2015). Enhanced detection of eosinophils simultaneously with other leukocyte subsets using flow cytometry (TECH2P.902). The Journal of Immunology. 194(1_Supplement). 206.12–206.12. 1 indexed citations

13.

Gommoll, Carl, Suresh Durgam, Maju Mathews, et al.. (2015). A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER. Depression and Anxiety. 32(6). 451–459. 34 indexed citations

14.

Mathews, Maju, Carl Gommoll, Dalei Chen, René Núñez, & Arif Khan. (2014). Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder. International Clinical Psychopharmacology. 30(2). 67–74. 57 indexed citations

15.

Bakish, David, Anjana Bose, Carl Gommoll, et al.. (2014). Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study. Journal of Psychiatry and Neuroscience. 39(1). 40–49. 56 indexed citations

16.

Citrome, Leslie, Carl Gommoll, Xiongwen Tang, René Núñez, & Maju Mathews. (2014). Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder. International Clinical Psychopharmacology. 30(2). 75–81. 8 indexed citations

17.

Croft, Harry A., Nunzio Pomara, Carl Gommoll, et al.. (2014). Efficacy and Safety of Vilazodone in Major Depressive Disorder. The Journal of Clinical Psychiatry. 75(11). e1291–e1298. 52 indexed citations

18.

Rodríguez, Mikhail Benet, et al.. (2011). La hiperreactividad cardiovascular: un nuevo factor asociado al síndrome metabólico. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Rodríguez, Mikhail Benet, et al.. (2007). Prevalencia de síndrome metabólico en los trabajadores de la Facultad de Ciencias Médicas de Cienfuegos.. 3(2). 22–27. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact